Related Experiment Video
Updated: Jul 21, 2025

Standardized Technique of Aortic Valve Re-implantation for Valve-sparing Aortic Root Replacement
Published on: December 11, 2017
Long-Term Survival among Octogenarians Undergoing Aortic Valve Replacement with or without Simultaneous Coronary
Hannah Masraf1, Davorin Sef1, Sirr Ling Chin1
1Wessex Cardiothoracic Centre, University Hospital Southampton, Southampton SO16 6YD, UK.
Insights
Adding coronary artery bypass grafting (CABG) to aortic valve replacement (AVR) in octogenarians did not impact long-term survival, but increased in-hospital mortality. Heart team discussion is crucial for these complex cases.
Area of Science:
- Cardiology
- Cardiac Surgery
- Geriatric Medicine
Background:
- The necessity and impact of combining coronary artery bypass grafting (CABG) with aortic valve replacement (AVR) in elderly patients (octogenarians) remain subjects of ongoing debate.
- This study investigates the characteristics and long-term survival outcomes for octogenarians undergoing isolated AVR versus those receiving both AVR and CABG.
Purpose of the Study:
- To compare the long-term survival and postoperative outcomes of octogenarians undergoing isolated aortic valve replacement (AVR) versus those undergoing AVR combined with coronary artery bypass grafting (CABG).
- To identify predictors of mortality in both groups and assess whether concomitant CABG independently affects long-term survival.
Main Methods:
- Retrospective analysis of octogenarian patients undergoing AVR with or without CABG between 2000 and 2022 at a tertiary cardiac center.
- Exclusion of patients with redo procedures, emergent surgeries, or other concomitant operations.
- Primary endpoints included 30-day and long-term survival; secondary endpoints covered early postoperative outcomes and survival determinants, analyzed using logistic and Cox regression models.
Main Results:
- A total of 1011 patients underwent isolated AVR and 1055 underwent AVR + CABG. 30-day and long-term survival rates were comparable between the two groups.
- Median postoperative survival was similar (7.1 years for AVR vs. 6.6 years for AVR + CABG; p=0.21).
- Concomitant CABG was not an independent predictor of adverse long-term survival (HR: 0.89; p=0.09), though it was associated with higher in-hospital mortality.
Conclusions:
- The addition of CABG to AVR in octogenarians does not significantly alter long-term survival outcomes.
- Octogenarians undergoing AVR + CABG experienced higher in-hospital mortality compared to those undergoing isolated AVR.
- Individualized treatment decisions for these patients should be made through thorough heart team consultations.
Background:
The impact of concomitant coronary artery bypass grafting (CABG) on aortic valve replacement (AVR) in octogenarians is still debated. We analyzed the characteristics and long-term survival of octogenarians undergoing isolated AVR and AVR + CABG.
Methods:
All octogenarians who consecutively underwent AVR with or without concomitant CABG at our tertiary cardiac center between 2000 and 2022 were included. Patients with redo, emergent, or any other concomitant procedures were excluded. The primary endpoints were 30-day and long-term survival. The secondary endpoints were early postoperative outcomes and determinants of long-term survival. Univariable and multivariable logistic regression analyses were performed to identify independent predictors of 30-day mortality, and Cox regression analysis was performed for predictors of adverse long-term survival.
Results:
A total of 1011 patients who underwent AVR (83.0 [81.0-85.0] years, 42.0% males) and 1055 with AVR + CABG (83.0 [81.2-85.4] years, 66.1% males) were included in our study. Survival at 30 days and at 1, 3, and 5 years in the AVR group was 97.9%, 91.5%, 80.5%, and 66.2%, respectively, while in the AVR + CABG group it was 96.2%, 89.6%, 77.7%, and 64.7%, respectively. There was no significant difference in median postoperative survival between the AVR and AVR + CABG groups (7.1 years [IQR: 6.7-7.5] vs. 6.6 years [IQR: 6.3-7.2], respectively, p = 0.21). Significant predictors of adverse long-term survival in the AVR group included age (hazard ratio (HR): 1.09; 95% CI: 1.06-1.12, p < 0.001), previous MI (HR: 2.08; 95% CI: 1.32-3.28, p = 0.002), and chronic kidney disease (HR 2.07; 95% CI: 1.33-3.23, p = 0.001), while in the AVR + CABG group they included age (HR: 1.06; 95% CI: 1.04-1.10, p < 0.001) and diabetes mellitus (HR: 1.48; 95% CI: 1.15-1.89, p = 0.002). Concomitant CABG was not an independent risk factor for adverse long-term survival (HR: 0.89; 95% CI: 0.77-1.02, p = 0.09).
Conclusions:
The long-term survival of octogenarians who underwent AVR or AVR + CABG was similar and was not affected by adding concomitant CABG. However, octogenarians who underwent concomitant CABG with AVR had significantly higher in-hospital mortality. Each decision should be discussed within the heart team.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Mitral Stenosis III: Medical Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management

